Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Kyntra Bio, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q4 2025
- Shares held
- 1.03M
- +66.1K (+6.8%) vs. Q4 2025
- Total value
- $7.01M
- −$1.49M (−17.5%) vs. Q4 2025
- New holders
- 8
- 5 more added
- Sold out
- 8
- 8 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $7.54M |
| Q1 2026 | 32 | $7.01M |
| Q4 2025 | 34 | $10.1M |
| Q3 2025 | 32 | $13.9M |
| Q2 2025 | 30 | $5.62M |
| Q1 2025 | 56 | $10.2M |
| Q4 2024 | 70 | $19.2M |
| Q3 2024 | 72 | $18.3M |
| Q2 2024 | 102 | $50.4M |
| Q1 2024 | 111 | $143.9M |
| Q4 2023 | 100 | $62.1M |
| Q3 2023 | 110 | $59.0M |
| Q2 2023 | 153 | $207.9M |
| Q1 2023 | 173 | $1.42B |
| Q4 2022 | 145 | $1.20B |
| Q3 2022 | 152 | $950.1M |
| Q2 2022 | 152 | $746.9M |
| Q1 2022 | 158 | $816.6M |
| Q4 2021 | 164 | $934.6M |
| Q3 2021 | 165 | $656.8M |
| Q2 2021 | 176 | $1.80B |
| Q1 2021 | 199 | $2.47B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Smithfield Trust Co | 1 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $7 | 0.00% | +1 | New |
| CFG Wealth Management Services, Inc. | 3 | $20 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12 | $78 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 26 | $176 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 50 | $339 | 0.00% | +1+2.0% | Added |
| Royal Bank of Canada | 137 | $1.00K | 0.00% | −1−0.7% | Reduced |
| SBI Securities Co., Ltd. | 152 | $1.03K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 180 | $1.22K | 0.00% | +78+76.5% | Added |
| National Bank of Canada | 193 | $1.30K | 0.00% | +193 | New |
| Harbour Investments, Inc. | 200 | $1.36K | 0.00% | +200 | New |
| Tower Research Capital LLC (TRC) | 332 | $2.25K | 0.00% | +116+53.7% | Added |
| Morgan Stanley | 488 | $3.31K | 0.00% | −5,436−91.8% | Reduced |
| Axiom Investment Management LLC | 704 | $4.77K | 0.00% | +704 | New |
| Vanguard Global Advisers, LLC | 1,424 | $9.65K | 0.00% | +1,424 | New |
| Group One Trading, L.P. | 4,492 | $30.5K | 0.00% | −96−2.1% | Reduced |
| ADAR1 Capital Management, LLC | 10,469 | $71.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,228 | $82.9K | 0.00% | −269−2.2% | Reduced |
| State Street Corp | 20,284 | $137.5K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 22,566 | $153.0K | 0.09% | +22,566 | New |
| Vanguard Fiduciary Trust Co | 23,942 | $162.3K | 0.00% | +23,942 | New |
| Renaissance Technologies LLC | 27,481 | $186.3K | 0.00% | −4,200−13.3% | Reduced |
| UBS Group AG | 27,591 | $187.1K | 0.00% | +18,159+192.5% | Added |
| HighTower Advisors, LLC | 39,744 | $269.5K | 0.00% | −20.0% | Reduced |
| Geode Capital Management, LLC | 45,998 | $311.9K | 0.00% | +2,294+5.2% | Added |
| Two Sigma Investments, LP | 49,511 | $335.7K | 0.00% | −11,700−19.1% | Reduced |
| BlackRock, Inc. | 84,331 | $571.8K | 0.00% | −359−0.4% | Reduced |
| Acadian Asset Management LLC | 105,585 | $714.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 156,607 | $1.06M | 0.00% | +156,607 | New |
| Armistice Capital, LLC | 400,000 | $2.71M | 0.09% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −32,502−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −30,420−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,809−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,756−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −12,852−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −12,186−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −10,013−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −595−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |